Needham & Company raised its price objective and issued a buy rating for Allot Ltd., alongside analyst updates from Cantor Fitzgerald and required SEC filings.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company raised its price objective and issued a buy rating for Allot Ltd., alongside analyst updates from Cantor Fitzgerald and required SEC filings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Needham & Company
American independent investment bank and asset management firm
-
SEC
Slovak company
Related events
- Berenberg Bank raised a price target and gave a 'hold' rating on Eli Lilly and Company, alongside filing required reports with the SEC.
- Needham & Company cut its target price and set a buy rating for Applied Optoelectronics, while Raymond James Financial reiterated an outperform rating. MarketBeat provided consensus data.
- A company is receiving analyst price targets and ratings, concurrent with institutional investors filing required Form 13F reports with the SEC.
- Bank of America lifted its price objective and issued a 'buy' rating for BridgeBio Pharma, concurrent with a required institutional investment filing.
- Price targets for UDR were adjusted by Cantor Fitzgerald, Scotiabank, and Royal Bank of Canada on May 26, 2026.